Coartem
Novartis reaches 300 million free antimalarial treatments
December 9, 2015Manufacturing and Production, Research and Development Coartem, Novartis, antimalarial treatment, malaria, non-profit
Novartis has reached a delivery milestone of 300 million paediatric antimalarial treatments, having supplied its Coartem dispersible without profit to …
Novartis receives WHO nod for malaria drug Coartem
July 17, 2015Manufacturing and Production Coartem, Novartis, WHO, antimalarial, malaria, world health organization
The World Health Organization will add Novartis’ antimalarial treatment Coartem to the prequalified list of vaccines that is supplies to …
Novartis may axe 1,000 jobs in Diovan wake
January 23, 2014Manufacturing and Production, Sales and Marketing Coartem, Diovan, Novartis, cuts
Novartis will shut down a plant in New York State that made heart drug Diovan and malaria treatment Coartem as …
Latest content
Scots neonatal innovations target hearing loss and earlier care
August 28, 2026
Agentis Health Group acquires Clinical Pharmacist Solutions
August 26, 2026
